Evidence in favour
- 4 distinct acquisition events survive duplicate and security-type controls.
- Participation spans 7 named insiders rather than one filing source.
- The latest qualifying evidence is fresh, dated 04 Sep 2026.
Company insider dossier
Embecta Corp insider intelligence
EMBC filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.
72/100
Conviction accumulation
84/100 confidence- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Latest evidence
- 4 Sep 2026
Investment committee read
Conviction accumulation
Priced common-share acquisitions carry more weighted evidence than disposals after freshness, role, size, and duplicate controls.
Research constructive setupsDecision risks
- Reported purpose is unavailable in this feed, so even priced common-share transactions need filing context.
Price confirmation map
Weekly price with common-share events
Acquisitions and disposals are aligned to the nearest completed weekly bar.
Mar 2025Sep 2026
Weekly closeCommon-share acquisitionCommon-share disposal
Market confirmation
Price and trend context
- Latest close
- 4.94 USD
- One-week move
- -14.8%
- Four-week move
- -2.9%
- Fair-value gap
- -57.9%
- Trend signal
- Inactive
- Relative strength
- -49.9
Directional balance
Controlled event mix
66.7%acquisition
- Acquisition events
- 4
- Disposal events
- 2
- Net value
- $514.4K
Cadence
Twelve-week filing pressure
Volume shows attention. Controlled events determine direction.
029 Jun
006 Jul
013 Jul
020 Jul
027 Jul
103 Aug
410 Aug
017 Aug
024 Aug
131 Aug
007 Sep
014 Sep
Named participants
Insider conviction by person
ELGUICZE, JACOBSVP and CFO721 events
HOMBACH, ROBERT J.Director721 events
KURDIKAR, DEVDATTDirector, President and CEO721 events
MANN, JEFFREY ZPres, Pharm Svc&Prod Mgmt, CLO721 events
ROTH, ANTHONY M.VP, Chief Accounting Officer500 events
MORRIS, MILTON MAYODirector281 events
CASNER, JEANChief Human Resources Officer281 events
Evidence quality
Security and transaction context
Role architecture
Who is participating
Transaction evidence
Auditable EMBC filing ledger
Showing 1 to 7 of 7.
MORRIS, MILTON MAYODirector
DisposalCommon equity
6293 sharesCommon Stock
$37.0KDirectional evidence
HOMBACH, ROBERT J.Director
AcquisitionCommon equity
45000 sharesCommon Stock
$223.8KDirectional evidence
KURDIKAR, DEVDATTDirector, President and CEO
AcquisitionCommon equity
30000 sharesCommon Stock
$140.9KDirectional evidence
MANN, JEFFREY ZPres, Pharm Svc&Prod Mgmt, CLO
AcquisitionCommon equity
20000 sharesCommon Stock
$99.8KDirectional evidence
ELGUICZE, JACOBSVP and CFO
AcquisitionCommon equity
20000 sharesCommon Stock
$93.4KDirectional evidence
CASNER, JEANChief Human Resources Officer
DisposalCommon equity
1480 sharesCommon Stock
$6.5KDirectional evidence
ROTH, ANTHONY M.VP, Chief Accounting Officer
AcquisitionCommon equity
30000 sharesCommon Stock
Not reportedContext evidence
Reading the dossier
Direction and confidence are separate
Conviction
The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.
Confidence
Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.
Disposals
Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.
Price confirmation
The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.
Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.